Schmidt, Ralph; Majer, Istvan; Román, Natalia García; … - In: Health Economics Review 7 (2017) 47, pp. 1-8
Background: Respiratory syncytial virus (RSV) infection remains one of the major reasons of re-hospitalization among children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus placebo, in Spain, from the societal perspective, using...
